Whole-body hypothermia within hours of birth failed to improve outcomes in preterm infants less than 36 weeks' gestational age with hypoxic-ischemic encephalopathy. Death or moderate or severe ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study. The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A Virginia-based biotech company has announced dosing of ...

Researchers at UHealth-;the University of Miami Health System and the University of Miami Miller School of Medicine have shown that, in two cases, COVID-19 infection breached the placenta and caused ...

Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of newborn mortality and morbidity worldwide, and lowering the baby’s body temperature—called therapeutic hypothermia—is often used ...

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences (“ReAlta”), Inc., a clinical stage, rare disease company dedicated to harnessing the power of the immune system to address life threatening diseases ...

Study shows that perinatal arterial ischemic stroke often coexists with hypoxic-ischemic encephalopathy in infants receiving therapeutic hypothermia This article clearly shows that there are children ...

Global health research has long shown the devastating consequences that maternal deaths have on families and communities in developing countries where maternal mortality rates are high. But this ...

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to ...